Central Pacific Bank Trust Division Sells 133 Shares of Oracle Corporation $ORCL

Central Pacific Bank Trust Division cut its holdings in Oracle Corporation (NYSE:ORCL) by 0.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 29,892 shares of the enterprise software provider’s stock after selling 133 shares during the period. Oracle accounts for 0.8% of Central Pacific Bank Trust Division’s investment portfolio, making the stock its 15th biggest position. Central Pacific Bank Trust Division’s holdings in Oracle were worth $6,535,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ORCL. Brighton Jones LLC boosted its holdings in Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after buying an additional 100,494 shares during the period. Revolve Wealth Partners LLC boosted its holdings in Oracle by 8.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after buying an additional 404 shares during the period. ProShare Advisors LLC boosted its holdings in Oracle by 6.1% in the 4th quarter. ProShare Advisors LLC now owns 366,034 shares of the enterprise software provider’s stock worth $60,996,000 after buying an additional 20,991 shares during the period. Sig Brokerage LP bought a new position in Oracle in the 4th quarter worth approximately $498,000. Finally, Shell Asset Management Co. boosted its holdings in Oracle by 205.3% in the 4th quarter. Shell Asset Management Co. now owns 22,259 shares of the enterprise software provider’s stock worth $3,709,000 after buying an additional 14,968 shares during the period. 42.44% of the stock is owned by institutional investors.

Oracle Stock Performance

Oracle stock opened at $292.07 on Friday. The firm’s fifty day moving average price is $244.69 and its 200-day moving average price is $190.37. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.75 and a current ratio of 0.62. The stock has a market cap of $820.38 billion, a P/E ratio of 67.61, a price-to-earnings-growth ratio of 4.10 and a beta of 1.46. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm had revenue of $15.90 billion for the quarter, compared to analysts’ expectations of $15.58 billion. During the same quarter last year, the company posted $1.63 EPS. The business’s quarterly revenue was up 11.3% on a year-over-year basis. On average, equities research analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

Insider Activity at Oracle

In related news, insider Clayton M. Magouyrk sold 15,000 shares of the stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the transaction, the insider owned 60,722 shares of the company’s stock, valued at approximately $13,000,580.20. This trade represents a 19.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Naomi O. Seligman sold 3,303 shares of the stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total transaction of $770,655.96. Following the transaction, the director directly owned 31,447 shares in the company, valued at approximately $7,337,214.04. This represents a 9.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,183 shares of company stock worth $10,353,198 in the last 90 days. Corporate insiders own 42.20% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Melius Research increased their target price on shares of Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research note on Wednesday. Loop Capital set a $135.00 target price on shares of Oracle in a research note on Tuesday, June 10th. BMO Capital Markets set a $345.00 target price on shares of Oracle in a research note on Wednesday. Morgan Stanley increased their target price on shares of Oracle from $175.00 to $246.00 and gave the stock an “equal weight” rating in a research note on Monday, September 8th. Finally, Mizuho increased their target price on shares of Oracle from $300.00 to $350.00 and gave the stock an “outperform” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, Oracle has an average rating of “Moderate Buy” and a consensus price target of $296.84.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.